JPS5645447A - Tripeptides* their manufacture and composition containing them - Google Patents

Tripeptides* their manufacture and composition containing them

Info

Publication number
JPS5645447A
JPS5645447A JP8770580A JP8770580A JPS5645447A JP S5645447 A JPS5645447 A JP S5645447A JP 8770580 A JP8770580 A JP 8770580A JP 8770580 A JP8770580 A JP 8770580A JP S5645447 A JPS5645447 A JP S5645447A
Authority
JP
Japan
Prior art keywords
tripeptides
manufacture
composition containing
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8770580A
Other languages
English (en)
Other versions
JPH0159275B2 (ja
Inventor
Bushiodon Jiyan
Fuarujiyu Danieru
Jieemu Kuroodo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Industries SA
Original Assignee
Rhone Poulenc Industries SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Industries SA filed Critical Rhone Poulenc Industries SA
Publication of JPS5645447A publication Critical patent/JPS5645447A/ja
Publication of JPH0159275B2 publication Critical patent/JPH0159275B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP8770580A 1979-06-29 1980-06-27 Tripeptides* their manufacture and composition containing them Granted JPS5645447A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7916844A FR2460289A1 (fr) 1979-06-29 1979-06-29 Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent

Publications (2)

Publication Number Publication Date
JPS5645447A true JPS5645447A (en) 1981-04-25
JPH0159275B2 JPH0159275B2 (ja) 1989-12-15

Family

ID=9227278

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8770580A Granted JPS5645447A (en) 1979-06-29 1980-06-27 Tripeptides* their manufacture and composition containing them

Country Status (16)

Country Link
US (1) US4916119A (ja)
JP (1) JPS5645447A (ja)
AU (2) AU5969880A (ja)
BE (1) BE884076A (ja)
CH (1) CH647789A5 (ja)
DE (1) DE3024369A1 (ja)
DK (1) DK154434C (ja)
FR (1) FR2460289A1 (ja)
GB (1) GB2053230B (ja)
IE (1) IE49950B1 (ja)
IT (1) IT1131847B (ja)
LU (1) LU82569A1 (ja)
NL (1) NL8003761A (ja)
NZ (1) NZ194178A (ja)
SE (1) SE448301B (ja)
ZA (1) ZA803886B (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same
JPS57114556A (en) * 1980-10-27 1982-07-16 Fujisawa Pharmaceut Co Ltd Novel peptide compound and its preparation
JPS57140751A (en) * 1981-01-29 1982-08-31 Fujisawa Pharmaceut Co Ltd Novel peptide, its preparation and use
JPS57145845A (en) * 1981-01-29 1982-09-09 Fujisawa Pharmaceut Co Ltd Novel peptide and its preparation
JPS5835121A (ja) * 1981-08-20 1983-03-01 ビラス・ヴィー・リクハイト 免疫刺激性補助剤からなる抗原及び免疫療法におけるその使用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
FR2496654A1 (fr) * 1980-12-19 1982-06-25 Rhone Poulenc Sante Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
FR2619108B1 (fr) * 1987-08-07 1989-12-01 Rhone Poulenc Sante Procede de preparation de l'acide n6-benzyloxycarbonyl diamino-2,6 pimelamique sous les formes l,l ou d,d ou racemique
US7078165B2 (en) * 2003-03-27 2006-07-18 Institut Pasteur Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5576850A (en) * 1978-10-19 1980-06-10 Anvar Waterrsoluble compounds derived from extract of streptomyces stimulosus*their manufactures and immunologic adjuvant composition
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0011283B1 (en) * 1978-11-14 1982-07-28 Fujisawa Pharmaceutical Co., Ltd. New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US4335111A (en) * 1978-12-22 1982-06-15 Agence National De Valorisation De La Recherche (Anvar) Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5576850A (en) * 1978-10-19 1980-06-10 Anvar Waterrsoluble compounds derived from extract of streptomyces stimulosus*their manufactures and immunologic adjuvant composition
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same
JPH0113463B2 (ja) * 1979-07-31 1989-03-06 Fujisawa Pharmaceutical Co
JPS57114556A (en) * 1980-10-27 1982-07-16 Fujisawa Pharmaceut Co Ltd Novel peptide compound and its preparation
JPH0325437B2 (ja) * 1980-10-27 1991-04-05 Fujisawa Pharmaceutical Co
JPS57140751A (en) * 1981-01-29 1982-08-31 Fujisawa Pharmaceut Co Ltd Novel peptide, its preparation and use
JPS57145845A (en) * 1981-01-29 1982-09-09 Fujisawa Pharmaceut Co Ltd Novel peptide and its preparation
JPS5835121A (ja) * 1981-08-20 1983-03-01 ビラス・ヴィー・リクハイト 免疫刺激性補助剤からなる抗原及び免疫療法におけるその使用

Also Published As

Publication number Publication date
DE3024369A1 (de) 1981-01-15
ZA803886B (en) 1981-06-24
JPH0159275B2 (ja) 1989-12-15
DK154434C (da) 1989-04-10
IE49950B1 (en) 1986-01-22
GB2053230A (en) 1981-02-04
LU82569A1 (fr) 1981-02-02
AU5969880A (en) 1981-01-08
BE884076A (fr) 1980-12-29
NL8003761A (nl) 1980-12-31
US4916119A (en) 1990-04-10
DK154434B (da) 1988-11-14
SE448301B (sv) 1987-02-09
GB2053230B (en) 1983-03-16
SE8004791L (sv) 1980-12-30
NZ194178A (en) 1983-11-18
FR2460289B1 (ja) 1983-09-30
DK277180A (da) 1980-12-30
IE801340L (en) 1980-12-29
IT8023074A0 (it) 1980-06-26
AU546524B1 (en) 1985-09-05
CH647789A5 (fr) 1985-02-15
FR2460289A1 (fr) 1981-01-23
IT1131847B (it) 1986-06-25

Similar Documents

Publication Publication Date Title
JPS5636440A (en) Tetrapeptide and pentapeptide* manufacture thereof and composition containing them
JPS55133465A (en) Coating composition and its manufacture
GB2066262B (en) N-adamantane-substituted tetrapeptide amides production thereof and compositions containing them
DE3066091D1 (en) Film forming composition and uses thereof
GB2051788B (en) 3 - thiovinyl - cephalosporins their preparation and compositions containing them
JPS568354A (en) Novel tripeptide and said manufacture
ZA801246B (en) Compounds and compositions
JPS54148734A (en) Nnhaloacetylphenylaminocarbonyloxime*its manufacture and composition
JPS5659743A (en) Pharmaceutic nnpropionylsarcosineanilides* their manufacture and blend composition containing them
ZA805646B (en) Compounds and compositions
JPS5594385A (en) Tetrahydrofuran derivatives*their manufacture and herbicidal composition containing them
PH16288A (en) Benzodiazepine compounds and compositions thereof
JPS5645448A (en) Peptide* its manufacture and composition containing it
JPS5645447A (en) Tripeptides* their manufacture and composition containing them
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
DE3067811D1 (en) Ammelinium beta-octamolybdate and composition containing same
GB2058099B (en) Composition and process
JPS54145695A (en) Alkylcarbapenems*their manufacture and composition
JPS5647453A (en) Improved paint composition and its manufacture
ZA803098B (en) Didodecylammonium beta-octamolybdate and composition containing same
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
JPS56108790A (en) Novel pyrrolobenzotriazepines*their manufacture and pharmaceutic composition containing them
JPS5639067A (en) Pyrrolidineedione derivatives and mildewcidal composition containing them
JPS55154980A (en) Novel 33thivinyllcephalosporins* their manufacture and composition containing them
JPS5629590A (en) 100halooeehomoeburnane derivatives* their manufacture and medicinal composition containing them